Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,906 JPY | -6.37% | -3.64% | -0.19% |
Apr. 26 | Japan's Nikkei extends early gains as BOJ holds rates steady | RE |
Apr. 26 | Japan's Nikkei rises as chip shares rebound; BOJ decision in focus | RE |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- With a 2024 P/E ratio at 21.73 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- With an enterprise value anticipated at 4.16 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.19% | 74.89B | B | ||
+0.09% | 46.52B | A- | ||
-4.19% | 30.82B | C | ||
+9.85% | 18.19B | B | ||
-10.05% | 11.54B | B | ||
+6.39% | 11.24B | A- | ||
-8.09% | 9.73B | - | ||
+2.79% | 9.4B | A- | ||
+6.35% | 9.37B | C- | ||
+3.85% | 8.11B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4063 Stock
- Ratings Shin-Etsu Chemical Co., Ltd.